• Something wrong with this record ?

Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization

E. Randárová, H. Nakamura, R. Islam, M. Studenovský, H. Mamoru, J. Fang, P. Chytil, T. Etrych

. 2020 ; 106 (-) : 256-266. [pub] 20200211

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Here, we describe innovative synthesis of well-defined biocompatible N-(2-hydroxypropyl) methacrylamide (HPMA)-based polymer carriers and their drug conjugates with pirarubicin intended for controlled drug delivery and pH-triggered drug activation in tumor tissue. Polymer carrier synthesis was optimized to obtain well-defined linear HPMA-based polymer precursor with dispersity close to 1 and molar mass close to renal threshold with minimal synthesis steps. The developed synthesis enables preparation of tailored polymer nanomedicines with highly enhanced biological behavior in vivo, especially the biodistribution, urine elimination, tumor accumulation and anticancer activity. STATEMENT OF SIGNIFICANCE: The manuscript reports on novel synthesis and detailed physicochemical characterization and in vivo evaluation of well-defined biocompatible hydrophilic copolymers based on N-(2-hydroxypropyl)methacrylamide (HPMA) and their drug conjugates with pirarubicin enabling controlled drug delivery and pH-triggered drug activation in tumor tissue. Polymer carrier synthesis was optimized to obtain well-defined linear HPMA-based polymer precursor with minimal synthesis steps using controlled polymerization. Compared to previously published HPMA-based polymer drug conjugates whose polymer carriers were prepared by classical route via free radical polymerization, the newly prepared polymer drug conjugates exhibited enhanced biological behavior in vivo, especially the prolonged blood circulation, urine elimination, tumor accumulation and excellent anticancer activity. We believe that the newly prepared well-defined polymer conjugates could significantly enhance tumor therapy in humans.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012721
003      
CZ-PrNML
005      
20210507101534.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.actbio.2020.02.011 $2 doi
035    __
$a (PubMed)32058082
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Randárová, Eva $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic. Electronic address: koziolova@imc.cas.cz
245    10
$a Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization / $c E. Randárová, H. Nakamura, R. Islam, M. Studenovský, H. Mamoru, J. Fang, P. Chytil, T. Etrych
520    9_
$a Here, we describe innovative synthesis of well-defined biocompatible N-(2-hydroxypropyl) methacrylamide (HPMA)-based polymer carriers and their drug conjugates with pirarubicin intended for controlled drug delivery and pH-triggered drug activation in tumor tissue. Polymer carrier synthesis was optimized to obtain well-defined linear HPMA-based polymer precursor with dispersity close to 1 and molar mass close to renal threshold with minimal synthesis steps. The developed synthesis enables preparation of tailored polymer nanomedicines with highly enhanced biological behavior in vivo, especially the biodistribution, urine elimination, tumor accumulation and anticancer activity. STATEMENT OF SIGNIFICANCE: The manuscript reports on novel synthesis and detailed physicochemical characterization and in vivo evaluation of well-defined biocompatible hydrophilic copolymers based on N-(2-hydroxypropyl)methacrylamide (HPMA) and their drug conjugates with pirarubicin enabling controlled drug delivery and pH-triggered drug activation in tumor tissue. Polymer carrier synthesis was optimized to obtain well-defined linear HPMA-based polymer precursor with minimal synthesis steps using controlled polymerization. Compared to previously published HPMA-based polymer drug conjugates whose polymer carriers were prepared by classical route via free radical polymerization, the newly prepared polymer drug conjugates exhibited enhanced biological behavior in vivo, especially the prolonged blood circulation, urine elimination, tumor accumulation and excellent anticancer activity. We believe that the newly prepared well-defined polymer conjugates could significantly enhance tumor therapy in humans.
650    _2
$a akrylamidy $x chemická syntéza $x farmakokinetika $x terapeutické užití $7 D000178
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x chemická syntéza $x farmakokinetika $x terapeutické užití $7 D000970
650    _2
$a kapronáty $x chemická syntéza $x farmakokinetika $x terapeutické užití $7 D002208
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a doxorubicin $x analogy a deriváty $x chemická syntéza $x farmakokinetika $x terapeutické užití $7 D004317
650    _2
$a lékové transportní systémy $7 D016503
650    _2
$a myši $7 D051379
650    _2
$a nanomedicína $x metody $7 D050997
650    _2
$a polymerizace $7 D058105
650    _2
$a experimentální sarkom $x farmakoterapie $7 D012513
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nakamura, Hideaki $u Faculty of Pharmaceutical Sciences, Sojo University, Ikeda 4-22-1, Nishi-ku, Kumamoto, 860-0082, Japan
700    1_
$a Islam, Rayhanul $u Faculty of Pharmaceutical Sciences, Sojo University, Ikeda 4-22-1, Nishi-ku, Kumamoto, 860-0082, Japan
700    1_
$a Studenovský, Martin $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic
700    1_
$a Mamoru, Haratake $u Faculty of Pharmaceutical Sciences, Sojo University, Ikeda 4-22-1, Nishi-ku, Kumamoto, 860-0082, Japan
700    1_
$a Fang, Jun $u Faculty of Pharmaceutical Sciences, Sojo University, Ikeda 4-22-1, Nishi-ku, Kumamoto, 860-0082, Japan
700    1_
$a Chytil, Petr $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic
700    1_
$a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic
773    0_
$w MED00008542 $t Acta biomaterialia $x 1878-7568 $g Roč. 106, č. - (2020), s. 256-266
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32058082 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101534 $b ABA008
999    __
$a ok $b bmc $g 1650977 $s 1133100
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 106 $c - $d 256-266 $e 20200211 $i 1878-7568 $m Acta biomaterialia $n Acta Biomater $x MED00008542
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...